Literature DB >> 14516181

Management and prevention of tetanus.

Richard F Edlich1, Lisa G Hill, Chandra A Mahler, Mary Jude Cox, Daniel G Becker, Jed H Horowitz, Larry S Nichter, Marcus L Martin, William C Lineweaver.   

Abstract

The World Health Organization was committed to eliminating neonatal tetanus by 1995. Three years after this date, the infection killed over 400,000 babies a year, even though a safe, effective vaccine had been available for most of this century. The frequency of tetanus in the developing world epitomizes the healthcare disparity between the developed and the developing world. Consequently, the priority of the medical profession must be prevention, with the development of simpler immunization schedules with longer protection. Consequently, the purpose of this collective review is to provide an overview to the management of tetanus as well as to review the immunization strategy that will prevent this potentially deadly illness. Tetanus is caused by Cloistridium tetani, which is an obligate anaerobic, gram-positive rod that is motile and readily forms endospores. Although C. tetani is located everywhere, the disease is encountered largely in underdeveloped, overcrowded, and economically disadvantaged countries. C. tetani is widespread in the feces of domestic animals and humans, while spores of C. tetani are abundant in soil and in the environment surrounding the habitation of humans and animals. Tetanus usually follows deep penetrating wounds where anaerobic bacterial growth is facilitated. Three basic forms of tetanus may be distinguished: local, cephalic, and generalized. At least 80% of the cases are the generalized form. In the adult patient, the most characteristic sign of generalized tetanus is lockjaw, or trismus. The diagnosis of tetanus is most frequently made on clinical manifestations, rather than on bacteriologic findings. The three objectives of management of tetanus are: (1) to provide supportive care until the tetanospasmin that is fixed in tissue has been metabolized; (2) to neutralize circulating toxin; and (3) to remove the source of tetanospasmin. Because there is essentially no immunity to tetanus toxoid, the only effective way to control tetanus is by prophylactic immunization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14516181

Source DB:  PubMed          Journal:  J Long Term Eff Med Implants        ISSN: 1050-6934


  16 in total

1.  Isolation and Antibiogram of Clostridium tetani from Clinically Diagnosed Tetanus Patients.

Authors:  Hajra Hanif; Awais Anjum; Naeem Ali; Asif Jamal; Muhammad Imran; Bashir Ahmad; Muhammad Ishtiaq Ali
Journal:  Am J Trop Med Hyg       Date:  2015-07-14       Impact factor: 2.345

2.  Prevalence and genotypic characteristics of Clostridium difficile in a closed and integrated human and swine population.

Authors:  Keri N Norman; H Morgan Scott; Roger B Harvey; Bo Norby; Michael E Hume; Kathleen Andrews
Journal:  Appl Environ Microbiol       Date:  2011-07-01       Impact factor: 4.792

3.  Two cases of acute dysphagia.

Authors:  R S Bhadauria; P V Padman
Journal:  Med J Armed Forces India       Date:  2012-08-14

Review 4.  Maxillofacial injuries due to animal bites.

Authors:  Shruti Chhabra; Naveen Chhabra; Shivani Gaba
Journal:  J Maxillofac Oral Surg       Date:  2013-10-10

Review 5.  Burn wound infections.

Authors:  Deirdre Church; Sameer Elsayed; Owen Reid; Brent Winston; Robert Lindsay
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

6.  Cephalic tetanus from penetrating orbital wound.

Authors:  Eloïse Guyennet; Jean-Laurent Guyomard; Emilie Barnay; Franck Jegoux; Jean-François Charlin
Journal:  Case Rep Med       Date:  2009-05-24

7.  Dissecting interactions between nucleosides and germination receptors in Bacillus cereus 569 spores.

Authors:  Tetyana Dodatko; Monique Akoachere; Nadia Jimenez; Zadkiel Alvarez; Ernesto Abel-Santos
Journal:  Microbiology (Reading)       Date:  2009-12-24       Impact factor: 2.777

Review 8.  The Ger receptor family from sporulating bacteria.

Authors:  Christian Ross; Ernesto Abel-Santos
Journal:  Curr Issues Mol Biol       Date:  2010       Impact factor: 2.081

9.  Challenges of tracheostomy in patients managed for severe tetanus in a developing country.

Authors:  Ayotunde James Fasunla
Journal:  Int J Prev Med       Date:  2010

10.  Tetanus as cause of mass die-off of captive Japanese macaques, Japan, 2008.

Authors:  Tomomi Nakano; Shin-ichi Nakamura; Akihiko Yamamoto; Motohide Takahashi; Yumi Une
Journal:  Emerg Infect Dis       Date:  2012-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.